Manufacturing, Expression Systems

Lonza Invests in Microbial Development Lab Expansion

November 18, 2021

Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.

KGI Team Adapts Vaccine Development Work to Address COVID-19

August 12, 2021

A research team at the Keck Graduate Institute will work to adapt its decade-long low-cost vaccine R&D for developing countries into a COVID-19 vaccine.

Catalent Biologics Launches New Cell Line Expression Technology

July 22, 2021

Catalent Biologics has launched its new cell line expression technology, GPEx Lightning, which aims to shorten drug substance development timelines by up to three months.

Thermo Fisher Scientific’s Clinic Solution Aims to Accelerate Biologic Drug Development

June 30, 2021

Thermo Fisher Scientific has introduced its new Quick to Clinic solution, which is designed to accelerate biologic drug development from discovery to the IND phase in a shortened period.

MilliporeSigma Launches Lentiviral Production Platform for Cell and Gene Therapies

October 16, 2020

The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.

iBio and Planet Biotechnology Partner to Develop COVID-19 Therapeutic

September 02, 2020

The companies will collaborate on the production of a novel anti-SARS-CoV-2 immunoadhesin in iBio’s FastPharming manufacturing system.

GigaGen Highlights Research Describing New Class of Drugs for Potential COVID-19 Therapy

August 28, 2020

In the study, GigaGen presents a novel technology for producing a new class of drug, recombinant hyperimmunes, that may potentially generate new COVID-19 therapies.

Absolute Antibody Launches New, High-Throughput Recombinant Antibody Production Service

March 05, 2020

The technology enables the rapid production of large numbers of recombinant antibodies at 80-mL scale.

Dyadic Achieves G2 Human-Like Glycosylation Milestone

February 27, 2020

The company presented data on its G2 glycosylation studies at the 15th European Conference on Fungal Genetics in Rome on Feb. 19, 2020.

GE Healthcare Launches Viral Vector-Based Gene Therapy Manufacturing

October 28, 2019

GE Healthcare Life Sciences’ KUBio box is an integrated, flexible biomanufacturing environment for viral vector-based gene therapies.